Playlist

People's Artist of Turkmenistan Annagul Gurdova celebrates her 75th birthday

11 Jun. 09:14

Source

On June 10, the legendary vocalist and People's Artist of Turkmenistan, Annagul Gurdova, celebrated her 75th birthday. This landmark personal anniversary beautifully coincided with another historic milestone in the acclaimed performer's life — the 70th anniversary of her continuous creative and stage career.

Born in the capital city of Ashgabat, Annagul Gurdova discovered her profound connection to music during early childhood. She began singing when she was just three years old, and her exceptional talent quickly secured her invitations to participate in state radio broadcasts and specialized children's television programs. Throughout her school years, the future icon dedicated herself to rigorous vocal training, constantly refining her performance techniques.

Although she pursued higher education in law and successfully practiced as a legal professional for a period of time, Annagul Gurdova remained unyielding in her devotion to the performing arts and instrumental music. She never abandoned her musical career and currently continues her professional journey as a leading soloist at the Cultural and Business Center of the "Turkmengas" State Concern.

Over her decades-long, illustrious artistic journey, the singer has performed a vast repertoire of classical masterpieces crafted by prominent Turkmen composers, as well as songs adapted from the works of celebrated national poets. Many of her signature compositions have achieved widespread national acclaim, embedding themselves into the golden heritage of Turkmen pop music and remaining beloved by multiple generations of listeners.

















US Scientists Develop Drug That Mimics Exercise Effects

Today in 10:05

Source

American researchers have initiated trials for a new pharmaceutical compound designated as ENV-308, designed to replicate the physiological effects of intensive physical training. Formulated in tablet form, the medication aims to trigger the body's metabolic responses similar to those experienced during exercise.

Scientists at Enveda utilized the Lac-Phe molecule as the core component for this development. Naturally produced by the body during vigorous exertion, this molecule transmits signals to the brain that suppress appetite and signal satiety.

Preclinical trials conducted on animal models demonstrated significant positive results. The tablets effectively reduced hunger levels and facilitated weight loss while entirely preserving existing muscle mass.

Researchers have successfully completed the first phase of clinical trials, confirming the safety of the drug for human use. Future studies will focus on evaluating the compound's impact on metabolism and exploring its potential combination with established therapeutics such as Ozempic.